Comprehensive Overview of PRUCALOPRIDE SUCCINATE API (CAS No: 74381-14-5) Manufactured by Swapnroop Drugs & Pharmaceuticals

Q1: What is PRUCALOPRIDE SUCCINATE API manufactured by Swapnroop Drugs & Pharmaceuticals?

Answer:

🌿 PRUCALOPRIDE SUCCINATE API is an active pharmaceutical ingredient (API) developed and manufactured by Swapnroop Drugs & Pharmaceuticals. It belongs to the class of selective serotonin 5-HT4 receptor agonists. This means it specifically activates serotonin receptors in the gastrointestinal tract to stimulate motility and improve bowel movement.

💊 Therapeutic Purpose:
PRUCALOPRIDE SUCCINATE API is primarily used for the treatment of chronic idiopathic constipation (CIC) in adults, especially when standard laxatives fail to provide relief. It works by enhancing colonic peristalsis, thereby facilitating regular bowel movements and reducing discomfort associated with constipation.

⚗️ Mechanism of Action:

  • It selectively binds to 5-HT4 receptors on the smooth muscle of the colon.

  • This triggers acetylcholine release, stimulating intestinal motility.

  • It improves frequency, consistency, and ease of bowel movements.

🌟 Key Features of PRUCALOPRIDE SUCCINATE API by Swapnroop Drugs & Pharmaceuticals:

  • High purity and consistency, suitable for formulation in tablets and other dosage forms.

  • Produced under stringent GMP (Good Manufacturing Practices) conditions, ensuring quality and safety.

  • Stable chemical properties that allow for long shelf life when stored properly.

📌 Applications:

  • Formulation of oral tablets for chronic constipation management.

  • Can be combined in research formulations to develop novel gastrointestinal therapies.

🛡️ Safety Profile:

  • Generally well-tolerated in adults.

  • Side effects may include headache, nausea, abdominal pain, or diarrhea (these are usually mild and temporary).

✨ Summary:
In essence, PRUCALOPRIDE SUCCINATE API is a high-quality, selective serotonin agonist produced by Swapnroop Drugs & Pharmaceuticals to aid in effective management of chronic constipation, providing a reliable solution for patients with inadequate response to traditional laxatives.



Q2: What is PRUCALOPRIDE SUCCINATE API by Swapnroop Drugs and Pharmaceuticals used for?

Answer:

💊 Therapeutic Use:
PRUCALOPRIDE SUCCINATE API is primarily used for treating chronic idiopathic constipation (CIC) in adults, especially when conventional laxatives fail.

🌟 How it Helps:

  • Stimulates colonic motility by acting on 5-HT4 serotonin receptors in the gastrointestinal tract.

  • Promotes regular bowel movements, improving stool consistency and reducing straining.

  • Enhances intestinal transit time, providing relief from abdominal discomfort, bloating, and sluggish bowel movements.

🧬 Additional Potential Uses (Investigational):

  • May support other gastrointestinal motility disorders under research.

  • Can be explored for combination therapies targeting functional bowel disorders.

⚠️ Important Note:

  • Should be used under medical supervision, especially in patients with intestinal obstruction or severe inflammatory bowel disease.

Q3: What are the physicochemical properties of PRUCALOPRIDE SUCCINATE API Manufactured by Swapnroop Drugs and Pharmaceuticals?

Answer:

⚗️ Chemical Identity:

  • Chemical Name: (R)-3-(1-Propylpiperidin-4-yl)-1,2-benzisoxazole-5-carboxamide succinate

  • CAS Number: 74381-14-5

  • Molecular Formula: C20H29N3O7

  • Molecular Weight: 387.46 g/mol

🧪 Physical Properties:

  • Appearance: White to off-white crystalline powder

  • Solubility: Soluble in water and polar solvents; slightly soluble in alcohol

  • Melting Point: Approximately 210–215 °C

  • pH: Neutral to slightly acidic in aqueous solutions

  • Stability: Stable under normal storage conditions; sensitive to prolonged exposure to heat and moisture

🔬 Chemical Properties:

  • Exhibits high chemical purity (>99%) when manufactured under GMP standards.

  • Non-hygroscopic, making it suitable for formulation into tablets and other solid dosage forms.

  • Resistant to light-induced degradation but should be stored in airtight containers.

✨ Summary:
PRUCALOPRIDE SUCCINATE API from Swapnroop Drugs & Pharmaceuticals is a stable, high-purity crystalline API with well-characterized physicochemical properties, making it ideal for therapeutic applications in chronic constipation.


Q4: How is PRUCALOPRIDE SUCCINATE API Manufactured by Swapnroop Drugs and Pharmaceuticals synthesized?

Answer:

⚗️ Synthesis Overview:
PRUCALOPRIDE SUCCINATE API is synthesized through a multi-step chemical process involving the formation of the benzisoxazole core and the piperidine side chain.

🔹 General Steps:

  1. Formation of the Benzisoxazole Core:

    • A substituted salicylamide undergoes cyclization to form the benzisoxazole nucleus.

  2. Introduction of the Piperidine Moiety:

    • The 4-piperidinyl group is attached through nucleophilic substitution reactions, ensuring the correct R-enantiomer is formed.

  3. Carboxamide Formation:

    • The carboxamide functional group is introduced, completing the main pharmacophore of the molecule.

  4. Conversion to Succinate Salt:

    • The free base is reacted with succinic acid to form the succinate salt, improving solubility and stability.

🛡️ Quality Considerations:

  • High-purity starting materials are used to avoid impurities.

  • GMP-compliant reactors and controlled temperature conditions ensure consistent yield and quality.

  • Enantiomeric purity is crucial for therapeutic efficacy.

✨ Summary:
The synthesis of PRUCALOPRIDE SUCCINATE API is complex but well-controlled, yielding a stable, high-purity API suitable for pharmaceutical formulations.

Q5: What are the different dosage forms of PRUCALOPRIDE SUCCINATE API Manufactured by Swapnroop Drugs and Pharmaceuticals?

Answer:

💊 Common Dosage Forms:

  1. Oral Tablets:

    • Immediate-release or film-coated tablets are the most common form for adults with chronic constipation.

  2. Capsules (less common):

    • Used in research or specialty formulations.

  3. Oral Solutions/Suspensions (investigational):

    • For patients with difficulty swallowing tablets.

🌟 Key Features:

  • Designed for precise dosing (e.g., 1 mg, 2 mg tablets).

  • Film-coated tablets enhance stability and mask bitterness.

  • All forms are made using PRUCALOPRIDE SUCCINATE API of high purity from Swapnroop Drugs & Pharmaceuticals.

🛡️ Considerations in Formulation:

  • Dosage forms must maintain chemical stability and bioavailability.

  • Protect the API from moisture and light during manufacturing.

  • Ensure uniformity of dose in each tablet or capsule.

✨ Summary:
The primary dosage form of PRUCALOPRIDE SUCCINATE API is oral tablets, optimized for efficacy, stability, and patient compliance, with other forms developed for special requirements or research purposes.

Q6: How are PRUCALOPRIDE SUCCINATE API Manufactured by Swapnroop Drugs and Pharmaceuticals dosage forms prepared?

Answer:

💊 Dosage Form Preparation Overview:
The preparation of PRUCALOPRIDE SUCCINATE API into solid oral dosage forms (like tablets or capsules) involves carefully controlled pharmaceutical processes to ensure stability, uniformity, and bioavailability.

🔹 Typical Tablet Preparation Steps:

  1. Weighing and Blending:

    • PRUCALOPRIDE SUCCINATE API is accurately weighed and blended with excipients such as binders, fillers, disintegrants, and lubricants.

  2. Granulation:

    • Wet or dry granulation may be used to improve flow properties and ensure uniform distribution of the API.

  3. Drying and Sieving:

    • Granules are dried to controlled moisture levels and passed through sieves for uniform particle size.

  4. Compression:

    • Granules are compressed into tablets using tablet presses, ensuring consistent weight and hardness.

  5. Coating (Optional):

    • Tablets may be film-coated to improve stability, mask bitterness, and facilitate swallowing.

🔹 Capsule Preparation (if applicable):

  • The API-excipient blend is filled into hard gelatin or HPMC capsules, ensuring precise dosing and uniformity.

🛡️ Quality Control:

  • Each batch undergoes in-process checks for weight, hardness, and content uniformity.

  • Ensures compliance with GMP standards.

✨ Summary:
The dosage forms of PRUCALOPRIDE SUCCINATE API are prepared using state-of-the-art pharmaceutical techniques, guaranteeing high-quality tablets and capsules for effective treatment of chronic constipation.

Q7: What is the appropriate dosage form of PRUCALOPRIDE SUCCINATE API Manufactured by Swapnroop Drugs and Pharmaceuticals?

Answer:

💊 Recommended Dosage Form:

  • The oral tablet is the preferred and most widely used dosage form for PRUCALOPRIDE SUCCINATE API.

🌟 Key Features:

  • Immediate-release film-coated tablets ensure rapid absorption.

  • Dosage is typically 1 mg or 2 mg per tablet, depending on patient needs and clinical guidance.

  • Suitable for adult patients with chronic idiopathic constipation.

⚖️ Rationale:

  • Tablets provide accurate dosing, stability, and ease of administration.

  • Other forms like capsules or oral solutions may be used for special cases but are less common.

🛡️ Considerations:

  • Should be taken whole with water, usually once daily.

  • Film coating protects the API from moisture and enhances patient compliance.

✨ Summary:
The oral tablet is the ideal dosage form for PRUCALOPRIDE SUCCINATE API from Swapnroop Drugs & Pharmaceuticals, offering effective, reliable, and patient-friendly treatment for chronic constipation.


Q8: When should PRUCALOPRIDE SUCCINATE API Manufactured by Swapnroop Drugs and Pharmaceuticals be taken?

Answer:

🕘 Timing and Administration:

  • PRUCALOPRIDE SUCCINATE API is typically formulated as oral tablets and is taken once daily.

  • It is recommended to take the tablet at the same time each day to maintain consistent blood levels.

💧 Administration Tips:

  • Take with a full glass of water.

  • Can be taken with or without food, although taking it with food may reduce minor gastrointestinal discomfort.

⚠️ Special Considerations:

  • Patients with severe renal impairment may require dose adjustment.

  • Should not be used in cases of intestinal obstruction, severe inflammatory bowel disease, or hypersensitivity to the API.

✨ Summary:
Consistent once-daily administration of PRUCALOPRIDE SUCCINATE tablets ensures optimal efficacy in promoting regular bowel movements and relieving chronic constipation.

Q9: What are the effects and side effects of PRUCALOPRIDE SUCCINATE API manufactured by Swapnroop Drugs and Pharmaceuticals?

Answer:

🌟 Therapeutic Effects:

  • Stimulates bowel motility by activating 5-HT4 receptors in the colon.

  • Increases frequency of bowel movements and improves stool consistency.

  • Reduces straining and abdominal discomfort associated with chronic constipation.

  • Enhances overall gastrointestinal transit time for better digestion.

⚠️ Common Side Effects:

  • Headache 💆‍♂️

  • Nausea 🤢

  • Abdominal pain or cramps 🤕

  • Diarrhea 💦

  • Flatulence (gas) 💨

🛡️ Less Common but Serious Side Effects:

  • Severe allergic reactions (rash, swelling, difficulty breathing) 🚨

  • Heart rhythm disturbances (rare) ❤️‍🩹

  • Severe gastrointestinal pain or obstruction

💡 Important Notes:

  • Most side effects are mild to moderate and often resolve after a few days.

  • Patients should consult a doctor if side effects persist or worsen.

✨ Summary:
PRUCALOPRIDE SUCCINATE API from Swapnroop Drugs & Pharmaceuticals is effective in relieving chronic constipation, with a generally tolerable side effect profile, though patients should monitor for rare but serious reactions.


Q10: How is PRUCALOPRIDE SUCCINATE API Manufactured by Swapnroop Drugs and Pharmaceuticals tested?

Answer:

🔬 Testing Overview:
PRUCALOPRIDE SUCCINATE API undergoes rigorous testing to ensure quality, purity, safety, and compliance with pharmaceutical standards. Swapnroop Drugs & Pharmaceuticals uses GMP-compliant laboratories and validated analytical methods.

🧪 Key Testing Methods:

  1. Identity Testing:

    • Confirms the chemical structure using techniques like NMR (Nuclear Magnetic Resonance), IR (Infrared Spectroscopy), and Mass Spectrometry.

  2. Purity Analysis:

    • HPLC (High-Performance Liquid Chromatography) is used to quantify API purity (>99%).

    • Detects impurities and degradation products.

  3. Physicochemical Tests:

    • Melting point, solubility, pH, and appearance checks ensure consistency and stability.

  4. Microbial Testing:

    • Ensures the API is free from harmful microorganisms, especially for oral dosage forms.

  5. Assay and Content Uniformity:

    • Determines the exact amount of API in each batch to guarantee accurate dosing.

✨ Summary:
Swapnroop Drugs & Pharmaceuticals ensures PRUCALOPRIDE SUCCINATE API is high-quality, pure, and safe through comprehensive analytical and microbiological testing.

Q11: What tests are performed on PRUCALOPRIDE SUCCINATE API Manufactured by Swapnroop Drugs and Pharmaceuticals?

Answer:

🧪 Comprehensive Testing List:

  1. Identity Tests: ✅

    • NMR, IR, and UV-Vis spectroscopy

    • Confirms chemical structure and molecular integrity

  2. Purity & Assay Tests: ⚖️

    • HPLC for purity and impurity profiling

    • Titration or HPLC for content assay (>99% active API)

  3. Physical & Physicochemical Tests: 🧬

    • Appearance (color, crystalline form)

    • Melting point

    • Solubility and pH

    • Moisture content (Karl Fischer titration)

  4. Microbiological Tests: 🦠

    • Total viable count (TVC)

    • Tests for specific pathogens: E. coli, Salmonella, Pseudomonas

  5. Residual Solvent Tests: 💨

    • Gas Chromatography (GC) to ensure safe levels of solvents from synthesis

  6. Stability Testing: ⏳

    • Accelerated and long-term stability tests per ICH guidelines

    • Ensures API maintains efficacy and safety over shelf life

✨ Summary:
PRUCALOPRIDE SUCCINATE API from Swapnroop Drugs & Pharmaceuticals is subjected to stringent chemical, physical, microbiological, and stability tests to guarantee maximum quality, safety, and therapeutic efficacy.


Q12: What are the challenges in manufacturing PRUCALOPRIDE SUCCINATE API Manufactured by Swapnroop Drugs and Pharmaceuticals?

Answer:

⚗️ API Manufacturing Challenges:

  1. Complex Multi-Step Synthesis: 🧩

    • PRUCALOPRIDE SUCCINATE requires multiple chemical reactions, including formation of the benzisoxazole core and attachment of the piperidine side chain.

    • Each step must maintain high enantiomeric purity, which is critical for therapeutic activity.

  2. Purity Control: 🧪

    • Avoiding impurities and degradation products is challenging due to reactive intermediates.

    • Requires stringent monitoring using HPLC, NMR, and other analytical techniques.

  3. Yield Optimization: ⚖️

    • Multi-step reactions can reduce overall yield if not carefully controlled.

    • Optimization of temperature, solvents, and catalysts is crucial.

  4. Moisture and Light Sensitivity: 💧☀️

    • The API must be protected from humidity and UV light during synthesis and storage to prevent degradation.

  5. Regulatory Compliance: 📜

    • Manufacturing must meet GMP standards, including documentation, batch traceability, and quality assurance, adding operational complexity.

✨ Summary:
The production of PRUCALOPRIDE SUCCINATE API is technically demanding, requiring precise chemical control, high purity, and adherence to regulatory standards to produce a safe and effective API.

Q13: What are the challenges in manufacturing PRUCALOPRIDE SUCCINATE API Manufactured by Swapnroop Drugs and Pharmaceuticals dosage forms?

Answer:

💊 Dosage Form Manufacturing Challenges:

  1. Uniformity of Dosage: ⚖️

    • Ensuring each tablet or capsule contains precisely the same amount of API is critical for efficacy and safety.

    • Requires advanced blending, granulation, and compression techniques.

  2. Stability of the API: ⏳

    • PRUCALOPRIDE SUCCINATE is sensitive to moisture and heat, so dosage form manufacturing must protect the API during processing.

  3. Flow Properties and Compressibility: 🏭

    • The crystalline powder may have poor flow or compressibility, complicating tablet production.

    • Granulation or use of excipients may be needed to improve handling.

  4. Coating Challenges: 🎨

    • Film-coating tablets must adhere properly without affecting disintegration or dissolution.

    • Coating also helps mask taste and protect the API from degradation.

  5. Regulatory and Quality Assurance: 📋

    • Every batch of tablets must pass content uniformity, hardness, dissolution, and stability tests.

    • Compliance with GMP and pharmacopeial standards is mandatory.

✨ Summary:
Manufacturing PRUCALOPRIDE SUCCINATE dosage forms requires careful formulation and processing to maintain API stability, dosage accuracy, and patient compliance, making it a high-precision pharmaceutical process.


Q14: What are the storage conditions for PRUCALOPRIDE SUCCINATE API Manufactured by Swapnroop Drugs and Pharmaceuticals?

Answer:

🏭 Storage Overview:
Proper storage of PRUCALOPRIDE SUCCINATE API is essential to maintain stability, purity, and efficacy.

🔹 Recommended Conditions:

  1. Temperature: Store in a cool environment, typically 15–25 °C (room temperature).

  2. Humidity: Keep in a dry place, away from excess moisture, as the API can be hygroscopic.

  3. Light Protection: Store in tightly sealed, opaque containers to prevent degradation from UV light.

  4. Air Exposure: Minimize exposure to air and oxygen to maintain chemical stability.

🛡️ Packaging Consideration:

  • Use airtight, high-quality containers such as HDPE drums or glass bottles with desiccants.

✨ Summary:
PRUCALOPRIDE SUCCINATE API from Swapnroop Drugs & Pharmaceuticals must be stored in cool, dry, and light-protected conditions to ensure maximum stability and shelf life.

Q15: What is the packaging for PRUCALOPRIDE SUCCINATE API Manufactured by Swapnroop Drugs and Pharmaceuticals?

Answer:

📦 Packaging Overview:
Swapnroop Drugs & Pharmaceuticals ensures safe and GMP-compliant packaging for PRUCALOPRIDE SUCCINATE API to protect the API during storage and transportation.

🔹 Common Packaging Types:

  1. Primary Packaging:

    • HDPE drums, glass bottles, or polypropylene containers for bulk API.

    • Includes airtight seals and desiccants to prevent moisture absorption.

  2. Secondary Packaging:

    • Cardboard boxes or shrink-wrapped pallets for shipment.

    • Provides mechanical protection and labeling compliance.

🔹 Labeling Requirements:

  • API name, CAS number, batch number, manufacturing and expiry date

  • Storage conditions, handling precautions, and regulatory compliance information

🛡️ Additional Considerations:

  • Packaging materials are non-reactive with the API.

  • Designed to withstand transportation stress while maintaining API integrity.

✨ Summary:
PRUCALOPRIDE SUCCINATE API is packaged in airtight, moisture-proof, and light-protected containers by Swapnroop Drugs & Pharmaceuticals, ensuring safe storage, transport, and regulatory compliance.


Q16: What is the shelf life of PRUCALOPRIDE SUCCINATE API manufactured by Swapnroop Drugs and Pharmaceuticals?

Answer:

⏳ Shelf Life Overview:
The shelf life of PRUCALOPRIDE SUCCINATE API depends on storage conditions, packaging, and stability of the API. Swapnroop Drugs & Pharmaceuticals ensures that the API maintains its potency, purity, and safety throughout its shelf life.

🔹 Typical Shelf Life:

  • Usually 36 months (3 years) from the date of manufacture when stored under recommended conditions.

🔹 Factors Affecting Shelf Life:

  1. Temperature: Excessive heat can cause degradation. 🌡️

  2. Humidity: Moisture can affect API stability. 💧

  3. Light Exposure: UV light may degrade the chemical structure. ☀️

  4. Packaging Integrity: Damaged or non-airtight containers can reduce shelf life. 📦

🛡️ Quality Assurance:

  • Shelf life is validated through stability studies according to ICH guidelines.

  • Each batch comes with a manufacturing date, expiry date, and batch number to ensure traceability.

✨ Summary:
When stored properly in cool, dry, and light-protected conditions, PRUCALOPRIDE SUCCINATE API from Swapnroop Drugs & Pharmaceuticals maintains maximum efficacy and safety for up to 36 months, providing reliable quality for pharmaceutical formulation.



#PRUCALOPRIDE #PrucaloprideAPI #ChronicConstipationRelief #5HT4Agonist #GastroHealth #PharmaAPI #ActivePharmaceuticalIngredient #SwapnroopDrugs #SwapnroopPharmaceuticals #PharmaInnovation #DrugManufacturing #HighQualityAPI #PharmaceuticalExcellence #GlobalPharma #PharmaSolutions #MedicalResearch #HealthcareInnovation #PatientCare #PharmaIndustry #QualityAssured #PharmaceuticalDevelopment #APIManufacturing #GMPCompliance #ClinicalTherapy #PharmaScience #PharmaceuticalGrowth #ConstipationTreatment #TherapeuticSolutions #HealthAndWellness #PharmaExperts #DrugFormulation #BusinessGrowth #PharmaSuccess


        

 https://wa.me/+919420294801




Comments

Post a Comment

Popular posts from this blog

🌿 Probiotics IR Pellets – Fast-Acting Gut Health Solution by Swapnroop Drugs & Pharmaceuticals 🌿

Image
  🌿 Probiotics IR Pellets – Fast-Acting Gut Health Solution by Swapnroop Drugs & Pharmaceuticals 🌿 In today’s busy lifestyle, digestive issues, weak immunity, and imbalance in gut flora are becoming very common. To solve these challenges, Swapnroop Drugs & Pharmaceuticals brings you Probiotics IR Pellets — a scientifically designed, fast-acting probiotic delivery system that helps restore gut health naturally and quickly. 🔬 What Are Probiotics IR Pellets? Probiotics IR (Immediate Release) Pellets are small, uniform granules containing beneficial “good bacteria” 🦠 designed to release immediately after swallowing. Unlike EC (Enteric-Coated) pellets, IR pellets dissolve fast , helping probiotics become active right away in the upper gastrointestinal tract. These pellets are formulated by Swapnroop Drugs & Pharmaceuticals using advanced pelletization technology for: ✨ High stability ✨ Faster release ✨ Better absorption ✨ Enhanced viability of probiotic st...
Read more

🌱 Probiotics EC Pellets – Stabilized Gut Health Powerhouses by Swapnroop Drugs & Pharmaceuticals

Image
  🌱 Probiotics EC Pellets – Stabilized Gut Health Powerhouses by Swapnroop Drugs & Pharmaceuticals In today’s health-conscious world, probiotics have become essential for supporting digestive wellness, immunity, and overall health. Traditional probiotic products often struggle with poor stability , acid degradation , and low survival rates during transit through the stomach. To overcome these challenges, Swapnroop Drugs & Pharmaceuticals offers advanced Probiotics EC Pellets , designed to deliver maximum probiotic viability and targeted intestinal release. This blog explains the benefits, technology, manufacturing, and applications of Probiotics EC Pellets manufactured by Swapnroop Drugs & Pharmaceuticals . 🧬 What Are Probiotics EC Pellets by Swapnroop Drugs & Pharmaceuticals? Probiotics EC Pellets are enteric-coated spherical granules containing beneficial live microorganisms such as: Lactobacillus species Bifidobacterium species Saccharomyce...
Read more

Azithromycin Taste-Masked Powder: A Pediatric-Friendly Innovation by Swapnroop Drugs & Pharmaceuticals

Image
  🌟 Azithromycin Taste-Masked Powder – A Palatable Innovation by Swapnroop Drugs & Pharmaceuticals 🌟 ✨💊😷👶🧪🌈 When it comes to oral antibiotics, taste plays a major role —especially for children and elderly patients. Many APIs, including Azithromycin , have an inherently bitter taste, often leading to poor patient compliance. To overcome this challenge, Swapnroop Drugs & Pharmaceuticals proudly presents Azithromycin Taste-Masked Powder , engineered for superior palatability, stability, and effectiveness . 🌟💊🧁 🍭 What is Azithromycin Taste-Masked Powder? Azithromycin Taste-Masked Powder is a specialized formulation where the bitter taste of Azithromycin is blocked using advanced taste-masking techniques . This ensures a pleasant taste profile , making it ideal for oral suspensions , especially pediatric formulations. 👶❤️💧 💡 Why Taste Masking is Important? ✔️ Improves patient compliance 😊 ✔️ Reduces gag reflex 🤢❌ ✔️ Enhances overall medication expe...
Read more